PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
PURE BIOSCIENCE, INC.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026
- Market cap
- $7.33M
- P/E (TTM)
- –
- Dividend yield
- –
PURE BIOSCIENCE, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product [Member] | $2.20M | $1.96M | $1.87M | $1.81M | $3.70M | $6.92M | 100.0% | +12.4% |
| PURE Hard Surface [Member] | $2.00M | $1.86M | $1.79M | $1.50M | – | – | 90.8% | +7.4% |
| SILVERION [Member] | $203.00K | $97.00K | $85.00K | $315.00K | $134.05K | $210.66K | 9.2% | +109.3% |
| Royalty [Member] | $4.00K | $8.00K | $6.00K | $40.00K | $229.00K | – | 0.2% | -50.0% |
| PURE Hard Surface [Member] | – | – | – | $1.50M | $3.56M | $6.71M | – | – |
| SILVERION [Member] | – | – | – | $315.00K | $134.05K | – | – | – |
By region
From the segment and revenue-disaggregation notes of Pure Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.